603406.SH
天富龙
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 28.63
−1.82%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.4B | 3.5B | 3.8B | 3.3B | 2.6B |
| Cost of Revenue | 2.8B | 2.9B | 3.2B | 2.7B | 2.1B |
| Gross Profit | 601.2M | 625.4M | 633.7M | 610.8M | 485.8M |
| Operating Expenses | |||||
| R&D Expense | 126.4M | 130.7M | 136.2M | 117.3M | 93.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 83.8M | 80.7M | 74.4M | 74.1M | 61.8M |
| Selling & Marketing Expense | 25.7M | 25.8M | 24.3M | 17.6M | 18.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 258.0M | 254.7M | 246.6M | 220.0M | 182.9M |
| Cost and Expenses | 3.1B | 3.1B | 3.5B | 2.9B | 2.3B |
| Operating Income (EBIT) | 460.9M | 476.6M | 487.7M | 464.5M | 390.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 460.0M | 475.5M | 487.9M | 464.2M | 389.7M |
| Income Tax Expense | 29.0M | 33.6M | 34.3M | 33.0M | 31.7M |
| Bottom Line | |||||
| Net Income | 431.0M | 441.9M | 453.6M | 431.2M | 358.0M |
| Earnings from Cont. Ops | 431.0M | 441.9M | 453.6M | 431.2M | 358.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 431.0M | 441.9M | 453.6M | 431.2M | 358.0M |
| Per Share | |||||
| Basic EPS | CN¥1.16 | CN¥1.18 | CN¥1.26 | CN¥1.20 | CN¥0.99 |
| Diluted EPS | CN¥1.16 | CN¥1.18 | CN¥1.26 | CN¥1.20 | CN¥0.99 |
| Revenue Per Share | CN¥8.69 | CN¥9.35 | CN¥10.67 | CN¥9.28 | CN¥7.12 |
| Shares | |||||
| Basic Shares Outstanding | 393.8M | 374.5M | 360.0M | 359.4M | 361.6M |
| Diluted Shares Outstanding | 393.8M | 374.5M | 360.0M | 359.4M | 361.6M |
| Profitability Metrics | |||||
| EBITDA | — | 630.3M | 633.7M | 570.0M | 486.1M |
| D&A | — | 153.8M | 146.0M | 105.5M | 95.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026